البرزدارو
دالبر | Stocks - Tehran Stock Exchange (TSE)
داروهای شیمیایی و گیاهی
Sector:
داروهای شیمیایی و گیاهی
Market Type:
Stocks
Status:
Authorized
Last Price: 18,260 2.99
Close Price: 18,260
Financial Ratios
AGM
Interim
2026/05/20 Fiscal Year 2025/12/2112 Month | 2025/02/17 Fiscal Year 2024/12/2012 Month | 2024/06/01 Fiscal Year 2024/03/1912 Month | ||
|---|---|---|---|---|
Net Profit to Sales | 27.77 | 15.51 | 23.3 | |
Gross Profit to Sales | 33.73 | 15.51 | 27.14 | |
Operating Margin | 42.59 | 28.97 | 38.26 | |
Gross Profit to Sales | 48.16 | 31.85 | 39.93 | |
Net Profit to Gross Profit | 57.66 | 48.69 | 58.35 | |
Return on Assets (ROA) | 18.43 | 5.92 | 16.92 | |
Return on Capital (%) | 87.97 | 23.6 | 77.14 | |
Return on Equity (ROE) | 41.99 | 17.61 | 40.7 | |
Working Capital Return | 51.38 | 21.05 | 44.55 | |
Fixed Asset Return | 153.83 | 46.38 | 151.81 | |
Loan Benefit Assessment | 2.28 | 2.97 | 2.41 | |
Current Ratio | 1.73 | 1.49 | 1.78 | |
Quick Ratio | 1.37 | 1.17 | 1.34 | |
Liquidity Ratio | 0.1 | 0.02 | 0.02 | |
Net Working Capital | 23,972,102 | 13,452,963 | 16,447,940 | |
Current Assets Ratio | 0.85 | 0.86 | 0.87 | |
Inventory Turnover | 163.34 | 262.85 | 151.9 | |
Receivables Collection Period | 318.35 | 590.65 | 304.95 | |
Inventory to Working Capital | 0.49 | 0.65 | 0.56 | |
Working Capital Turnover | 1.85 | 1.36 | 1.91 | |
Fixed Asset Turnover | 5.54 | 2.99 | 6.52 | |
Total Asset Turnover | 0.66 | 0.38 | 0.73 | |
Debt Ratio | 0.56 | 0.66 | 0.58 | |
Debt to Equity | 1.28 | 1.97 | 1.41 | |
Long-Term Debt to Equity | 0.16 | 0.26 | 0.23 | |
Current Debt to Equity | 1.12 | 1.71 | 1.17 | |
Equity Ratio | 43.91 | 33.62 | 41.57 | |
Debt Coverage Ratio | 1.73 | 1.45 | 1.16 |